Digressioni

Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials

First Authors: Fabio Marsico and Stefania Paolillo Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Pansini, 5, I-80131 Naples, Italy. Glucagon-like peptide-1 (GLP-1) receptor agonists are recommended…

READ MORE